Category: Antibody Technologies
Antibody Technologies market research reports by Kalorama Information
-
Precision Cancer Therapeutics, 2022
Precision Cancer Therapeutics, 2022 Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million people are living with canc ... Read More
-
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Hundreds of test p ... Read More
-
Pharmaceutical Market Research Bundle (Monoclonal Antibody Markets, CMOs, Bioprocessing Markets, Biosimilar Drug Markets)
Kalorama Information Market Research Bundles allow customers to experience savings while obtaining a large amount of research on topics of importance in pharmaceuticals. This bundle represents essential trends in the pharmaceutical industry currently. It is combination of 4 complete Kalorama Infor ... Read More
-
What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])
What's Trending in Monoclonal Antibodies (Markets by Structure, by Target, and by Indication) There are several types of monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells (WBCs) that seek out and destroy harmful foreign substances – on the market and in development ... Read More
-
Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market
Potential Pipeline Disruptors: Innovative Pharmaceuticals in Alzheimer's Disease, Asthma and Cancer This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are ... Read More